ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Neuropace Inc

Neuropace Inc (NPCE)

13.39
0.40
(3.08%)
Closed April 28 4:00PM
13.36
-0.03
(-0.22%)
After Hours: 7:59PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
13.39
Bid
12.40
Ask
14.35
Volume
69,086
12.94 Day's Range 13.6785
3.795 52 Week Range 18.15
Market Cap
Previous Close
12.99
Open
13.03
Last Trade
1
@
13.11
Last Trade Time
Financial Volume
$ 918,747
VWAP
13.2986
Average Volume (3m)
108,473
Shares Outstanding
28,344,637
Dividend Yield
-
PE Ratio
-11.49
Earnings Per Share (EPS)
-1.16
Revenue
65.42M
Net Profit
-32.96M

About Neuropace Inc

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically ... NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
Neuropace Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NPCE. The last closing price for Neuropace was $12.99. Over the last year, Neuropace shares have traded in a share price range of $ 3.795 to $ 18.15.

Neuropace currently has 28,344,637 shares outstanding. The market capitalization of Neuropace is $378.68 million. Neuropace has a price to earnings ratio (PE ratio) of -11.49.

NPCE Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.39-2.8301886792513.7814.50512.949037113.88411743CS
4-0.01-0.074626865671613.415.774712.114578413.74969536CS
12-2.16-13.890675241215.5518.1512.110847314.31289294CS
267.02110.2040816336.3718.156.089389312.44322683CS
529.03207.1100917434.3618.153.7957049710.37459983CS
156-12.2-47.674872997325.5927.381.226800210.99532696CS
260-9.86-42.408602150523.2527.381.227275411.94646593CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Your Recent History

Delayed Upgrade Clock